Objective:

To summarize recent advancements in menopause research and clinical care.

Approach:

Key Findings:

• Menopause affects around half of the global population, yet research has been underfunded.
• Up to 80% of individuals experience vasomotor symptoms during menopause, which can last 4-7 years.
• Recent research has identified various risk factors for severe vasomotor symptoms, including socio-economic and lifestyle factors.
• New treatments, such as neurokinin 3 receptor antagonists, have been approved for managing vasomotor symptoms.

Interpretation:

Despite recent advancements, there are still significant research gaps and a need for improved treatment options and personalized care.

Limitations:

• More research is needed on the effects of new treatments compared to traditional hormone therapies.
• Clinical trials focusing on the perimenopause period are lacking.

Conclusion:

While important advances have been made in menopause research and treatment, further efforts are required to enhance care for those affected.

Sources:

• Hickey et al. Review
• Navarro et al. Review
Source

Based on findings from:

Menopause in the spotlight: important research and clinical advances

Nature Reviews Endocrinology, 2026.

https://www.nature.com/articles/s41574-026-01262-9

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.